What is Scleroderma
Systemic Scloerosis: Multisystem disease with involvement of skin and Raynauds
How does Systemic Sclerosis distinguish itself from localised scleroderma such as morphed
Latter: Do not involve organ disease and no vasospasm (Raynauds)
What gender does Scleroderma effect
Females
Peak incidence of Scleroderma
Between 30 and 50
Is Scleroderma common in children
No
Risk factors for Scleroderma
Pathophysiology for Scleroderma
Initial stage of scleroderma
What does continued vascular damage and increased vascular permeability and activation of endothelial cells lead to
What do these cell-cell and cell-matrix interactions stimulate
Production of cytokines and growth factors which mediate PROLIFERATION and ACTIVATION of vascular and connective tissue cells - particularly fibroblasts
What mediators activate fibroblasts
IL1, 4, 6, 8, TGF-B and PDGF
What do fibroblasts secrete in Scleroderma
Consequence of secreted COLLAGEN TYPE I + 2
Fibrosis in lower dermis of the skin and internal organs
What is the end-product of scleroderma
Clinical presentation of Scleroderma
What is limited cutaneous scleroderma
Why was it previously called CREST syndrome
Why is Diffuse cutaneous scloerderma different to limited cutaneous scleroderma
Skin changes more rapidly and more widespread
What organs are involved in diffuse cutaneous scleroderma
GI involvement in diffuse scleroderma
Renal involvement in diffuse scleroderma
2. Acute hypertensive crisis is a complication of renal involvement
Lung disease in diffuse scleroderma
Herat in diffuse scleroderma
Arrhythmias and conduction disturbances due to myocardial fibrosis
Diagnostics for Scleroderma